4
Changes in Ownership
ORAMED PHARMACEUTICALS INC. Filed Acc 0001178913-14-001299
Options or other derivatives
- President and CEO acquired 47,134 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
KIDRON NADAV · President and CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2014-04-09 | Grant or award : show line 1 in the form Stock Option (right to buy) | +47,134 | $12.45 | 2024-04-09 | 47,134 | 47,134 | D |
Loading xslF345X03/zk1414761.xml…